Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alternative and aberrant splicing of MDM2 mRNA in human cancer.

Cancer cell - 1 Jul 2002

Bartel Frank, Taubert Helge, Harris Linda C

Abstract excerpt

MDM2 has been characterized as a protein that binds to and facilitates degradation of the tumor suppressor p53. Interestingly, more than 40 different splice variants of MDM2 transcripts have been identified both in tumors and normal tissues, and the majority of these variants do not contain seque...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alternative Splicing
Share to Neoplasm Proteins
Share to Nuclear Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protein Isoforms

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-mdm2

Share to Tumor Cells, Cultured

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 12150820
DOI: 10.1016/s1535-6108(02)00091-0

Genes

MDM2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12150820-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alternative and aberrant splicing of MDM2 mRNA in human cancer.PMID 12150820Read ↗

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancerSemantic proximity Read ↗

Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.Semantic proximity Read ↗

An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and TumorigenesisSemantic proximity Read ↗

MDM4 (MDMX) and its Transcript VariantsSemantic proximity Read ↗

Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis.Semantic proximity Read ↗

Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cellsSemantic proximity Read ↗

Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancerSemantic proximity Read ↗

Novel MDM2 splice variants identified from oral squamous cell carcinoma.Semantic proximity Read ↗

Genotoxic Stress Induces Coordinately Regulated Alternative Splicing of the p53 Modulators MDM2 and MDM4Semantic proximity Read ↗

Identification and expression of a novel MDM4 splice variant in human glioma.Semantic proximity Read ↗

Conserved sequence elements in the final exon of MDM2-eight-exon skipping event reveal a ‘cassette regulon’ model of alternative splicing controlled by a distal regulatory elementSemantic proximity Read ↗

The regulation of MDM2 oncogene and its impact on human cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.